Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 75Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Uterine Cervical Dysplasia 2Small Cell Lung Carcinoma 2Neoplasms 2Malnutrition 2Lung Neoplasms 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Salivary Gland Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasms, Second Primary 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Kidney Diseases 1Gallbladder Neoplasms 1

Interventions

lenvatinib 3Surgical Procedures, Operative 3Hepatectomy 3Cholangiopancreatography, Endoscopic Retrograde 3Blood Specimen Collection 3Oxaliplatin 2Liquid Biopsy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Drug Therapy 2Base Sequence 2pembrolizumab 1gemcitabine-oxaliplatin regimen 1envafolimab 1Vascular Endothelial Growth Factor A 1Urination 1Tegafur 1Shadowing Technique, Histology 1S 1 (combination) 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Photochemotherapy 1Patient Reported Outcome Measures 1Pancreaticoduodenectomy 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microbiota 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cholangiocarcinoma × Cisplatin × Clear all
NCT06718257 2025-02-06

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Recruiting
300 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡